The majority of patients with late stage castration-resistant prostate cancer (CRPC) develop
bone metastases that often result in significant bone pain. Therapeutic palliation strategies …

Objective: To measure the potential radiation dose emitted by patients who have recently
undergone diagnostic nuclear medicine procedures, in order to establish optimal radiation …

The goal of this study is to investigate the effect of the location and width of a single lead
shield on the dose rate of staff and caregivers in a hospital room with an I-131 patient. The …

The purpose of this work is to evaluate the potential third-party radiation exposure from
patients undergoing therapy with 131 I for ablation of residual thyroid tumor or metastases …

Updated effective dose rate and exposure rate coefficients for age-specific receptors
representing members of the public were computed for external exposures from age-specific …

Nuclear medicine patients are a source of exposure and should receive instructions to
restrict contact time with different categories of people. The calculation of the restriction time …

Objective There is considerable variation in the national regulations of different countries for
the release of patients from hospitals after radioiodine therapy. Individual variations make …

This study investigated radiation exposures from nuclear medicine patients by systematically
comparing the dose rates calculated using various source models, ranging from simplified …

The use of unconventional or novel radionuclides for positron emission tomography (PET) is
becoming more prevalent in both nuclear medicine diagnosis and therapy. Many of these …

Radioiodine (131 I) therapies on younger children with thyroid cancer and neuroblastoma
can be challenging as they are required to be isolated for a period of time due to radiation …